REQUEST A DEMO
Total
USD $0.00
Search more companies

Concord Healthcare Group Co. Ltd. (China)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Concord Healthcare Group Co. Ltd. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

The Company was incorporated in the People's Republic of China (the “PRC”) on July 23, 2008 with limited liability under the Companies laws of the PRC. The Company share were listed on the Main Board of the Stock Exchange of Hong Kong Limited on Tuesday, January 9,2024. The Company's principal place of business is located in the PRC. The Company and its subsidiaries (the “Group”) are principally engaged in leasing of radiotherapy and diagnostic imaging equipment, trading of radiotherapy and diagnostic imaging equipment, provision of management and technical services to hospitals, sales and installing of medical equipment and software, and provision of premium cancer treatment services.
HISTORY
The following table sets forth major events and milestones in the development of business:
2008 The Company was established under the laws of the PRC and commenced operation of medical equipment, software and related services.
2011 The medical equipment, software and related services accumulated nine customers covering seven provinces in China as of December 31, 2011.
2014 Datong Hospital was established by the Group.
Datong Hospital, the first independent Class II cancer specialty hospital under control, received the Medical Institution Practicing License.
2016 The Company was became listed on the NEEQ.
2017 Datong Hospital commenced operation.
The Company was commenced the construction of Shanghai Hospital, which was expected to commence operation in January 2026.
2018 The Company was acquired Guangzhou Hospital and Shanghai Outpatient Center.
Shanghai Imaging Center was established by the Group together with other promoters.
2020 Shanghai Imaging Center, an independent imaging diagnostic center, commenced full operation.
The Company was acquired Guangzhou Outpatient Center.
The internally-formulated Practice Guideline for Total Body Irradiation Technology was approved by the National Cancer Center of China as the 2019
Radiation Therapy Quality Control Guidelines (2019 ), which was the first approved project hosted by a private medical institution in China.
The Company was launched Jiahe Yunying Remote Imaging Information Diagnosis Platform for medical equipment, software and related services.
2021 The Company was launched Jiahe Cloud Asset Management Platform for medical equipment, software and related services.
The Company was launched Jiahe Feiyun Intelligent Radiation Therapy Cloud Service Platform for medical equipment, software and related services.
The Company was launched Internet Hospital as a one-stop portal to connect cancer patients with comprehensive oncology healthcare resources.
Guangzhou Hospital, a comprehensive cancer hospital commenced operation.
The Company was acquired Beijing Healthingkon, an AI-orientated company which was certified by China Academy of China Medical Sciences for its top
notch AI-driven Traditional Chinese Medicine Tongue Diagnosis technology ensuing the application of AI engine.
2022 The Company was chosen by the National Cancer Center of China to be an editor for the formulation of the 2021 version of the National Standard of
Radiation Therapy Quality Control Guidelines, and have initiated two national standard formulation projects to develop Radiation Therapy Data Validation
Quality Control Practice Guidelines and Development Guidelines for the 5G-based Remote Radiation Therapy Plan Design, Implementation and Quality
Control Platform.
2023 The Company was chosen by the National Cancer Center of China to be an editor for the formulation of the 2023 version of the National Standard of
Radiation Therapy Quality Control Guidelines, and initiated a national standard formulation projects to develop Practice Guideline for Total Skin (E-beam)
Irradiation Technology.

Headquarters
Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District
Beijing; Beijing;

Contact Details: Purchase the Concord Healthcare Group Co. Ltd. report to view the information.

Website: http://www.concordmedical.com

Basic Information
Outstanding Shares:
Purchase the Concord Healthcare Group Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Concord Healthcare Group Co. Ltd. report to view the information.
Incorporation Date:
2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Guangzhou Concord Pharmacy Co., Ltd.
100%
Ningbo Jiahe Hospital Management Ltd.
100%
Shanghai Taizhi Medical Technology Service Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Concord Healthcare Group Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
98.3%
Total operating revenue
97.25%
Operating profit (EBIT)
23.26%
EBITDA
37.89%
Net Profit (Loss) for the Period
48.34%
Operating Profit Margin (ROS)
96.88%
Net Profit Margin
213.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?